Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clemens Wittenbecher, Ph.D.

Concepts

This page shows the publications Clemens Wittenbecher has written about Prospective Studies.
Connection Strength

0.303
  1. Lipid Profiles and Heart Failure Risk: Results From Two Prospective Studies. Circ Res. 2021 02 05; 128(3):309-320.
    View in: PubMed
    Score: 0.042
  2. Plasma N-Glycans as Emerging Biomarkers of Cardiometabolic Risk: A Prospective Investigation in the EPIC-Potsdam Cohort Study. Diabetes Care. 2020 03; 43(3):661-668.
    View in: PubMed
    Score: 0.039
  3. Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors. Diabetologia. 2019 12; 62(12):2211-2221.
    View in: PubMed
    Score: 0.038
  4. Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes. Diabetes. 2019 01; 68(1):188-197.
    View in: PubMed
    Score: 0.036
  5. Amino acids, lipid metabolites, and ferritin as potential mediators linking red meat consumption to type 2 diabetes. Am J Clin Nutr. 2015 Jun; 101(6):1241-50.
    View in: PubMed
    Score: 0.028
  6. Dairy consumption, plasma metabolites, and risk of type 2 diabetes. Am J Clin Nutr. 2021 07 01; 114(1):163-174.
    View in: PubMed
    Score: 0.011
  7. Mendelian Randomization Study on Amino Acid Metabolism Suggests Tyrosine as Causal Trait for Type 2 Diabetes. Nutrients. 2020 Dec 19; 12(12).
    View in: PubMed
    Score: 0.010
  8. Replacement of Red and Processed Meat With Other Food Sources of Protein and the Risk of Type 2 Diabetes in European Populations: The EPIC-InterAct Study. Diabetes Care. 2020 11; 43(11):2660-2667.
    View in: PubMed
    Score: 0.010
  9. A metabolomic study of red and processed meat intake and acylcarnitine concentrations in human urine and blood. Am J Clin Nutr. 2020 08 01; 112(2):381-388.
    View in: PubMed
    Score: 0.010
  10. Desaturase Activity and the Risk of Type 2 Diabetes and Coronary Artery Disease: A Mendelian Randomization Study. Nutrients. 2020 Jul 28; 12(8).
    View in: PubMed
    Score: 0.010
  11. Association of Chemerin Plasma Concentration With Risk of Colorectal Cancer. JAMA Netw Open. 2019 03 01; 2(3):e190896.
    View in: PubMed
    Score: 0.009
  12. Chemerin as a Biomarker Linking Inflammation and Cardiovascular Diseases. J Am Coll Cardiol. 2019 01 29; 73(3):378-379.
    View in: PubMed
    Score: 0.009
  13. Gaussian graphical models identified food intake networks and risk of type 2 diabetes, CVD, and cancer in the EPIC-Potsdam study. Eur J Nutr. 2019 Jun; 58(4):1673-1686.
    View in: PubMed
    Score: 0.009
  14. Red meat consumption and risk of cardiovascular diseases-is increased iron load a possible link? Am J Clin Nutr. 2018 01 01; 107(1):113-119.
    View in: PubMed
    Score: 0.009
  15. Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study. Sci Rep. 2017 10 26; 7(1):14171.
    View in: PubMed
    Score: 0.008
  16. Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study. Eur J Endocrinol. 2017 Oct; 177(4):277-286.
    View in: PubMed
    Score: 0.008
  17. Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. J Endocrinol Invest. 2016 Nov; 39(11):1347-1355.
    View in: PubMed
    Score: 0.008
  18. Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC-Potsdam Cohort Study. Cancer Res. 2016 07 01; 76(13):3862-71.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.